Zymeworks Inc (ZYME)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Ali Tehrani
Employees:
183
540-1385 WEST 8TH AVENUE, Vancouver, CANADA V6H 3V9
(604) 678-1388

Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer.

Data derived from most recent annual or quarterly report
Market Cap 1.067 Billion Shares Outstanding46.386 Million Avg 30-day Volume 709.372 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 59.03 / 22.42 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ZYME instead.

View recent insider trading info

Funds Holding ZYME (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZYME BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

4.9 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

POLVERINO ANTHONY J. CHIEF SCIENTIFIC OFFICER

  • Officer
113,933 2021-08-31 4

TEHRANI ALI CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
617,352 2021-07-15 5

KLOMPAS NEIL A CHIEF FINANCIAL OFFICER

  • Officer
11,470 2021-07-06 6

O'DRISCOLL KATHRYN CHIEF PEOPLE OFFICER

  • Officer
6,350 2021-07-06 5

PRIOUR JAMES CHIEF COMMERCIAL OFFICER

  • Officer
2,513 2021-07-06 4

JOSEPHSON NEIL INTERIM CHIEF MEDICAL OFFICER

  • Officer
2,054 2021-07-06 2

RENTON HOLLINGS

  • Director
9,000 2021-05-06 1

ZOTH LOTA S.

  • Director
9,000 2021-05-06 1

MAHONY SUSAN

  • Director
9,000 2021-05-06 1

NEU KELVIN

  • Director
9,000 2021-05-06 1

HILLAN KENNETH J.

  • Director
9,000 2021-05-06 1

SACKS NATALIE

  • Director
9,000 2021-05-06 1

COX TROY

  • Director
9,000 2021-05-06 1

HAUSMAN DIANA CHIEF MEDICAL OFFICER

  • Officer
69,252 2021-03-10 4

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
0 2020-05-08 0

BEDFORD NICK

  • Director
0 2019-05-06 0

POON DAVID KAI YUEN SEE REMARKS

  • Officer
0 2019-05-06 0

LILLY ELI & CO

  • 10% Owner
2,898,647 2019-01-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

POLVERINO ANTHONY J. - Officer CHIEF SCIENTIFIC OFFICER

2021-09-02 20:00:19 -0400 2021-08-31 M 4,900 $15.00 a 36,333 direct -1.3243 2.8642 -26.0548 11.1796 9 -26.0548 31

POLVERINO ANTHONY J. - Officer CHIEF SCIENTIFIC OFFICER

2021-09-02 20:00:19 -0400 2021-08-31 M 4,900 d 77,600 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ZYMEWORKS INC ZYME 2021-10-26 19:15:03 UTC -0.2275 0.2975 350000
ZYMEWORKS INC ZYME 2021-10-26 18:45:03 UTC -0.2275 0.2975 350000
ZYMEWORKS INC ZYME 2021-10-26 18:15:03 UTC -0.2275 0.2975 350000
ZYMEWORKS INC ZYME 2021-10-26 17:45:03 UTC -0.2275 0.2975 350000
ZYMEWORKS INC ZYME 2021-10-26 17:15:03 UTC -0.2275 0.2975 350000
ZYMEWORKS INC ZYME 2021-10-26 16:45:04 UTC -0.2331 0.3031 350000
ZYMEWORKS INC ZYME 2021-10-26 16:15:03 UTC -0.2331 0.3031 350000
ZYMEWORKS INC ZYME 2021-10-26 15:45:03 UTC -0.2331 0.3031 350000
ZYMEWORKS INC ZYME 2021-10-26 15:15:03 UTC -0.2331 0.3031 350000
ZYMEWORKS INC ZYME 2021-10-26 14:45:03 UTC -0.2157 0.2857 350000
ZYMEWORKS INC ZYME 2021-10-26 14:15:05 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-26 13:45:03 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-26 13:15:03 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-26 12:45:03 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-25 22:15:03 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-25 21:45:03 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-25 21:15:03 UTC -0.2157 0.2857 300000
ZYMEWORKS INC ZYME 2021-10-25 20:45:03 UTC -0.2619 0.3319 300000
ZYMEWORKS INC ZYME 2021-10-25 20:15:03 UTC -0.2619 0.3319 300000
ZYMEWORKS INC ZYME 2021-10-25 19:45:04 UTC -0.2619 0.3319 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund ZYME -111.0 shares, $-3937.17 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund ZYME -10.0 shares, $-354.7 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ZYME -90.0 shares, $-3192.3 2020-03-31 N-PORT

Elevate your investments